Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie E Buring

Showing results (341-350 of 616) with videos related to

Pageof 62
Sort By:
American Heart Journal|June 19, 2022
Statin-associated muscle symptoms in the VITamin D and OmegA-3 TriaL (VITAL)Pedro Engel Gonzalez, Mark A Hlatky, JoAnn E Manson, et al.
Frontiers in Neurology|March 1, 2021
Association of Genetic Variants With Migraine Subclassified by Clinical Symptoms in Adult FemalesJoe Kossowsky, Megan S Schuler, Franco Giulianini, et al.
Metabolism: Clinical and Experimental|February 6, 2008
Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive proteinEmily B Levitan, Nancy R Cook, Meir J Stampfer, et al.
Cancer Research|February 19, 2009
Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studiesShelley S Tworoger, Margaret A Gates, Margaret A Gate, et al.
BMJ (Clinical Research Ed.)|April 24, 2007
Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)Nancy R Cook, Jeffrey A Cutler, Eva Obarzanek, et al.
JAMA Cardiology|January 7, 2026
Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a)Ask Tybjærg Nordestgaard, Daniel I Chasman, Vinayaga Moorthy, et al.
Contemporary Clinical Trials|March 13, 2018
The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depressionOlivia I Okereke, Charles F Reynolds, David Mischoulon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Analgesic use and change in kidney function in apparently healthy menTobias Kurth, Robert J Glynn, Alexander M Walker, et al.
Clinical Chemistry|February 9, 2017
Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in WomenPatrick R Lawler, Akintunde O Akinkuolie, Paul M Ridker, et al.
Archives of Internal Medicine|January 14, 2009
Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up studyNancy R Cook, Eva Obarzanek, Jeffrey A Cutler, et al.
Pageof 62

Showing results (341-350 of 616) with videos related to

Sort By:
Pageof 62
American Heart Journal|June 19, 2022
Statin-associated muscle symptoms in the VITamin D and OmegA-3 TriaL (VITAL)Pedro Engel Gonzalez, Mark A Hlatky, JoAnn E Manson, et al.
Frontiers in Neurology|March 1, 2021
Association of Genetic Variants With Migraine Subclassified by Clinical Symptoms in Adult FemalesJoe Kossowsky, Megan S Schuler, Franco Giulianini, et al.
Metabolism: Clinical and Experimental|February 6, 2008
Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive proteinEmily B Levitan, Nancy R Cook, Meir J Stampfer, et al.
Cancer Research|February 19, 2009
Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studiesShelley S Tworoger, Margaret A Gates, Margaret A Gate, et al.
BMJ (Clinical Research Ed.)|April 24, 2007
Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)Nancy R Cook, Jeffrey A Cutler, Eva Obarzanek, et al.
JAMA Cardiology|January 7, 2026
Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a)Ask Tybjærg Nordestgaard, Daniel I Chasman, Vinayaga Moorthy, et al.
Contemporary Clinical Trials|March 13, 2018
The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depressionOlivia I Okereke, Charles F Reynolds, David Mischoulon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Analgesic use and change in kidney function in apparently healthy menTobias Kurth, Robert J Glynn, Alexander M Walker, et al.
Clinical Chemistry|February 9, 2017
Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in WomenPatrick R Lawler, Akintunde O Akinkuolie, Paul M Ridker, et al.
Archives of Internal Medicine|January 14, 2009
Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up studyNancy R Cook, Eva Obarzanek, Jeffrey A Cutler, et al.
Pageof 62